Search

Diane Shader Smith wrote a beautiful article commemorating the two-year anniversary of her daughter Mallory’s passing. Mallory passed away due to drug-resistant Burkholderia and cystic fibrosis. Diane remarks that Mallory's legacy lives on

Shelley Gibson (Baylor College of Medicine) and colleagues have published a paper describing the generation of phage libraries against three pathogens: E. coli, P. aeruginosa and Enterobacter cloacae. They've characterized the phages system

Yi Duan (UCSD) and colleagues have published an incredibly exciting paper showing that cytotoxin-secreting Enterococcus faecalis in the mouse gut is a cause of alcohol-induced liver disease in mice. Most excitingly, they used phages to targ

The Open Health Systems Colloquium and the International Bacteriophage Research Consortium will be hosting a lecture and panel discussion on "Charting a Path Toward Bacteriophage Therapy" on Nov. 19 from 6-8:30 PM at the India International

PhagoMed is looking for a high calibre business developer to join our team in Vienna, Austria. Role description: - Identify new business opportunities, incl. analyzing new indications to pursue, grant opportunities, co-development programs

PhagoMed is looking for a high calibre business developer to join our team in Vienna, Austria. Role description: - Identify new business opportunities, incl. analyzing new indications to pursue, grant opportunities, co-development programs

Krystyna Dąbrowska (Polish Academy of Sciences) and Stephen Abedon (Ohio State University) have published a review on what it means to do "pharmacologically aware" phage therapy, which takes into consideration the in vivo obstacles to phage

Armata Pharmaceuticals has addressed its shareholders with good news about how their company is progressing post-merger between C3J and AmpliPhi. The company also recently announced that it has received a Research and Development Tax Incent

Armata Pharmaceuticals has addressed its shareholders with good news about how their company is progressing post-merger between C3J and AmpliPhi. The company also recently announced that it has received a Research and Development Tax Incent

Krystyna Dąbrowska (Polish Academy of Sciences) and Stephen Abedon (Ohio State University) have published a review on what it means to do "pharmacologically aware" phage therapy, which takes into consideration the in vivo obstacles to phage

We collectively don’t know much about how phages work in cocktails, or how best to optimize phage therapy when multiple phages are combined. Rosanna Wright (University of York) and colleagues have shown, using P. aeruginosa and pairs of pha

Save the date for Phage Futures Congress 2020, coming up Feb 5-6, 2020 (note that the date has changed!) in Washington, DC, USA.

Save the date for Phage Futures Congress 2020, coming up Feb 5-6, 2020 (note that the date has changed!) in Washington, DC, USA.

Scientific American magazine just published a nice feature on where phage therapy is at today: great storytelling, nice visuals, plus input from several phage researchers on where phage therapy is going.

Scientific American magazine just published a nice feature on where phage therapy is at today: great storytelling, nice visuals, plus input from several phage researchers on where phage therapy is going.

We collectively don’t know much about how phages work in cocktails, or how best to optimize phage therapy when multiple phages are combined. Rosanna Wright (University of York) and colleagues have shown, using P. aeruginosa and pairs of pha

The Center for Innovative Phage Applications and Therapeutics (IPATH) at UCSD has published the first issue of its new quarterly newsletter. This quarter's issue features an interview with Dr. Hedieh Attai, a postdoc at IPATH, along with in

Here's a new phage therapy podcast episode featuring Dr. Aleksandra Petrovic-Fabijan and Dr. Ruby Lin from the Westmead Institute for Medical Research in Westmead, Australia. [Medical Journal of Australia Podcast, 21 mins]

Related to the new NIAID request for applications (RFA) for phage studies, here's a videocast of the NIAID council meeting where they discuss their phage interests and why they're going to fund phage studies now and in the future. Start wat

Michele Mutti and Lorenzo Corsini of the phage biotech company PhagoMed have published a review on GMP production of phages for therapy. They review the literature covering technical issues and approaches to increase robustness at each step